---
title: Vitamin D, Omegas, & Autoimmune
description: Results from a large trial of older adults in the U.S. were recently published in BMJ, detailing the outcome of a 5-year study evaluating the use of supplemental vitamin D and/or omega-3 fatty acids and the development of autoimmune disease. Part of the large-scale vitamin D and omega-3 trial (VITAL), it was randomized, double-blinded and placebo-controlled with nearly 26,000 participants over age 50 (mean 67.1). The study was a 2x2 factorial design; some subjects received 2000 IU cholecalciferol per day, some received 1 g/day fish oil (460 mg EPA & 380 mg DHA), some received both, while the remainder received only placebos.
---

[Research Forum ](https://info.bioticsresearch.com/researchforum)

# [Vitamin D, Omegas, & Autoimmune](https://info.bioticsresearch.com/researchforum/vitamin-d-omegas-autoimmune)

 Written by [The Biotics Research Team](https://info.bioticsresearch.com/researchforum/author/the-biotics-research-team) | Sep 30, 2022 3:35:36 PM

Results from a large trial of older adults in the U.S. were recently [published in *BMJ*](https://pubmed.ncbi.nlm.nih.gov/35082139/), detailing the outcome of a 5-year study evaluating the use of supplemental vitamin D and/or omega-3 fatty acids and the development of autoimmune disease. Part of the large-scale vitamin D and omega-3 trial (VITAL), it was randomized, double-blinded and placebo-controlled with nearly 26,000 participants over age 50 (mean 67.1). The study was a 2x2 factorial design; some subjects received 2000 IU cholecalciferol per day, some received 1 g/day fish oil (460 mg EPA & 380 mg DHA), some received both, while the remainder received only placebos.

Vitamin D supplementation, either alone or with fish oil, led to a lower incidence of autoimmune disease compared to placebo. When compared to the group receiving both placebos, those receiving only vitamin D had a 31% lower incidence, though if the first two years were excluded from analysis (pre-planned, to test for latent effects), this increased to 39%. There also appeared to be a greater benefit of vitamin D for participants with a lower body weight, with a somewhat linear relationship as [observed in previous studies](https://pubmed.ncbi.nlm.nih.gov/33534730/). For example, for a BMI of 18 the hazard ratio (HR) was 0.47, versus a HR of only 0.9 among those with a BMI of 30.

Although omega-3 supplementation was associated with a 26% lower incidence, this intervention was only of marginal significance (p = 0.07). However, when “probable” cases of autoimmune disease rather than “confirmed” cases were analyzed, omega-3 supplementation was associated with a significant 18% reduction in incidence, with a suggestion that effects were greater with a longer period of supplementation. It is an open question how protective these nutrients would be if taken for longer than 5 years, or beginning at an earlier age.

[View full post](https://info.bioticsresearch.com/researchforum/vitamin-d-omegas-autoimmune)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "The Biotics Research Team"
  },
  "dateModified" : "2022-09-30T15:35:36.807Z",
  "datePublished" : "2022-09-30T15:35:36Z",
  "headline" : "Vitamin D, Omegas, & Autoimmune",
  "image" : {
    "@type" : "ImageObject",
    "height" : 1393,
    "url" : "https://4004166.fs1.hubspotusercontent-na1.net/hubfs/4004166/iStock-1281676402.jpg",
    "width" : 2153
  },
  "mainEntityOfPage" : "https://info.bioticsresearch.com/researchforum/vitamin-d-omegas-autoimmune",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60,
      "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
      "width" : 60
    },
    "name" : "Research Forum"
  }
}
```